EMA
approval
· 2020-04-30
First triple combination therapy for asthma with optional electronic sensor
Summary
The European Medicines Agency announces the first triple combination therapy for asthma with an optional electronic sensor to monitor adherence and inhaler use.
Upgrade for the full analysis, importance score, and drug timeline.